Journal details
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
TAYLOR & FRANCIS LTD · ISSN 1742-5255 · eISSN 1744-7607
SCIEScopusMEDLINEPubMedPMC
Overview
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. ISSN 1742-5255 · eISSN 1744-7607. published by TAYLOR & FRANCIS LTD. England. Biochemistry & Molecular Biology · Pharmacology & Pharmacy · Toxicology. impact factor 4.5 (2025). JCR Q1. CAS Zone 3. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 33 articles · 2025: 87 articles · 2024: 111 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY?
The impact factor recorded for EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY is 4.5 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY?
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY is listed in CAS Zone 3.
Which databases index EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY?
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.